fda pulls tirzepatide FDA's decision creates uncertainty for patients—and leads to a lawsuit ENDOCRINOLOGIA Weekly Dose:2.5 mg Starting GLP-1 can change

fda pulls tirzepatide FDA's decision creates uncertainty for patients—and leads to a lawsuit ENDOCRINOLOGIA Weekly Dose:2.5 mg Starting GLP-1 can change

Starting GLP-1 can change more than your appetite. 💉✨ You may notice fewer cravings, smaller portions, less food noise, fewer late-night snacks, and a healthier relationship with food. 🥗🧠

The lawsuit follows an FDA announcement last week that Lilly determined its manufacturing capacity can meet “present and projected” national demand after a sustained shortage of the drug, which Lilly sells under the brand name Mounjaro for treating diabetes and as Zepbound for weight loss

ENDOCRINOLOGIA

Weekly Dose:2.5 mg

E.WallisK.le RouxC